LENZ Therapeutics (LENZ) Change in Account Payables (2022 - 2025)
LENZ Therapeutics (LENZ) has disclosed Change in Account Payables for 4 consecutive years, with -$156000.0 as the latest value for Q4 2025.
- Quarterly Change in Account Payables fell 111.82% to -$156000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$90000.0 through Dec 2025, up 97.9% year-over-year, with the annual reading at -$90000.0 for FY2025, 97.9% up from the prior year.
- Change in Account Payables for Q4 2025 was -$156000.0 at LENZ Therapeutics, down from $1.7 million in the prior quarter.
- The five-year high for Change in Account Payables was $1.7 million in Q3 2025, with the low at -$2.7 million in Q2 2024.
- Average Change in Account Payables over 4 years is -$364769.2, with a median of -$567000.0 recorded in 2023.
- The sharpest move saw Change in Account Payables crashed 197.42% in 2023, then soared 203.04% in 2025.
- Over 4 years, Change in Account Payables stood at -$1.1 million in 2022, then skyrocketed by 47.55% to -$567000.0 in 2023, then skyrocketed by 332.8% to $1.3 million in 2024, then plummeted by 111.82% to -$156000.0 in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods came in at -$156000.0, $1.7 million, and -$857000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.